Sigma Planning Corp’s Guardant Health GH Stock Holding History

Sigma Planning Corp’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,932	Closed	-$327K	–	1353
2022 Q1	$327K	Sell	4,932 -38	-0.8%	-$2.6K	0.01%	1016
2021 Q4	$497K	Sell	4,970 -420	-8%	-$43.4K	0.01%	858
2021 Q3	$674K	Sell	5,390 -1,622	-23%	-$193K	0.02%	691
2021 Q2	$871K	Buy	7,012 +2,859	+69%	+$385K	0.03%	607
2021 Q1	$634K	Sell	4,153 -3,143	-43%	-$475K	0.02%	679
2020 Q4	$940K	Sell	7,296 -7,624	-51%	-$877K	0.03%	462
2020 Q3	$1.67M	Buy	14,920 +3,861	+35%	+$353K	0.07%	276
2020 Q2	$897K	Buy	11,059 +233	+2%	+$18.8K	0.04%	417
2020 Q1	$753K	Buy	10,826 +3,281	+43%	+$252K	0.04%	385
2019 Q4	$590K	Sell	7,545 -6,348	-46%	-$457K	0.02%	546
2019 Q3	$887K	Buy	13,893 +5,125	+58%	+$451K	0.04%	401
2019 Q2	$757K	Buy	8,768 +4,700	+116%	+$359K	0.04%	418
2019 Q1	$312K	Buy	+4,068	New	+$226K	0.02%	659

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Sigma Planning Corp's GH Position: Q2 2022 in Review

Sigma Planning Corp sold out of Guardant Health (GH) in Q2 2022, closing a stake of 4,932 shares — an estimated $327K sold.

Sigma Planning Corp first reported a position in GH in Q1 2019 and held it in 13 quarters. The position peaked at $1.67M in Q3 2020. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

Sigma Planning Corp reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
Sigma Planning Corp sold 4,932 Guardant Health shares in Q2 2022, an estimated $327K.
Sigma Planning Corp first reported a position in Guardant Health in Q1 2019 and held it in 13 quarters.
Sigma Planning Corp's Guardant Health position peaked at $1.67M in Q3 2020.
332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Sigma Planning Corp's 13F filing for Q2 2022, filed 11 Aug 2022.